Teva Pharmaceutical Industries Ltd. Conference Call Announcement
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) has announced its plans to release financial results for the third quarter of 2024 on November 6, 2024. At 7:00 a.m. ET, a press release will be issued, followed by a conference call and live webcast scheduled for 8:00 a.m. ET on the same day.
How to Join the Conference Call
Those interested in participating in the call are encouraged to register in advance. This will allow access to either a local or toll-free phone number and a unique personal pin for the call. Taking part in this live discussion offers a great opportunity to hear directly from Teva’s leadership about the company's recent performance and future direction.
Live Webcast Availability
For those who prefer to join via the internet, a live webcast of the call will be accessible through Teva's official website at the time of the event. Following the call, listeners will have the chance to replay the webcast within 24 hours, ensuring that important updates and insights are available for review.
Understanding Teva's Market Position
Teva is not just a pharmaceutical company; it's a pioneering entity in global healthcare with more than 120 years of experience. With around 37,000 employees operating in 58 countries, Teva is at the forefront of innovative medical solutions. Their extensive portfolio includes generic drugs, and they are continually investing in research and development to enhance the quality and efficiency of their products.
Commitment to Innovation and Patient Care
At the heart of Teva’s operations lies a steadfast commitment to health improvement. The company empowers its vast workforce to push the limits of scientific innovation, thus playing a crucial role in advancing modern medicine. Teva's strategy not only focuses on maintaining current market positions but also aims for growth through increased innovation, reinforcing its status as a leader in the pharmaceutical industry.
Contact Information for Investors and Media
Teva wants to ensure that all interested parties have ample opportunity to engage with their team for insights and inquiries. Investors seeking more information can contact:
Ran Meir: +1 (267) 468-4475
Yael Ashman: +972 (3) 914 8262
Sanjeev Sharma: +1 (973) 658 2700
For media inquiries, communication can be directed to:
Kelley Dougherty: +1 (973) 832-2810
Eden Klein: +972 (3) 906 2645
Frequently Asked Questions
What is the date of the conference call?
The conference call will take place on November 6, 2024.
How can I participate in the call?
Participants should register in advance to receive dial-in information and a personal pin for the call.
Where can I find the webcast of the call?
The live webcast will be available on Teva's official website during the call.
What is the focus of the conference call?
The call will discuss Teva's financial results for the third quarter of 2024 and future outlook.
Who can I contact for additional information?
For investor inquiries, you can reach out to Ran Meir or the other contacts listed above.